Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mivavotinib (CB-659)
i
Other names:
CB-659, TAK 659, TAK659, TAK-659
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Calithera
Drug class:
FLT3 inhibitor, SYK inhibitor
Related drugs:
‹
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
ABT-869 (2)
HM43239 (2)
TG02 (2)
AG-1296 (1)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KC1036 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
NMS-088 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
GS-9973 (20)
fostamatinib (2)
ALXN2075 (2)
GS-9876 (2)
BAY-61-3606 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
ABT-869 (2)
HM43239 (2)
TG02 (2)
AG-1296 (1)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KC1036 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
NMS-088 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
GS-9973 (20)
fostamatinib (2)
ALXN2075 (2)
GS-9876 (2)
BAY-61-3606 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
FLT3 mutation + DNMT3A mutation
Acute Myelogenous Leukemia
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
FLT3 mutation + MLL mutation
Acute Myelogenous Leukemia
FLT3 mutation + MLL mutation
Acute Myelogenous Leukemia
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
FLT3 mutation + NPM1 mutation
Acute Myelogenous Leukemia
FLT3 mutation + NPM1 mutation
Acute Myelogenous Leukemia
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
MLL rearrangement
Acute Lymphocytic Leukemia
MLL rearrangement
Acute Lymphocytic Leukemia
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
CB-659
Sensitive: D – Preclinical
CB-659
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login